Halozyme Therapeutics Inc (NASDAQ:HALO)

18.54
Delayed Data
As of Feb 16
 -0.12 / -0.64%
Today’s Change
11.41
Today|||52-Week Range
21.13
-8.49%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Torley Helen I
President & Chief Executive Officer
Sale2/03/201824,111$18.37$442.9K+4.39%
Torley Helen I
President & Chief Executive Officer
Sale2/06/201815,493$18.25$282.7K+1.59%
Torley Helen I
President & Chief Executive Officer
Sale1/06/201811,649$19.46$226.7K-0.96%
Stelzer Laurie D
Chief Financial Officer & Senior Vice President
Sale2/03/20188,265$18.37$151.8K+4.39%
Third Security Llc
Director
Buy5/11/201710,000$10.37$103.7K+33.38%
Matsui Connie L
Director
Buy5/08/201710,000$10.37$103.7K+33.86%
Leonhardt Harry J
Chief Compliance Officer, SVP & General Counsel
Sale2/03/20185,605$18.37$103.0K+4.39%
Stelzer Laurie D
Chief Financial Officer & Senior Vice President
Sale6/15/20172,583$13.05$33.7K+42.07%
Leonhardt Harry J
Chief Compliance Officer, SVP & General Counsel
Sale4/13/20172,583$12.81$33.1K+44.73%
Third Security Llc
Director
Gift5/04/201714,135$0.00$0.00+31.02%
Page of 3